Halo Pharmaceutical, Inc. Email Format
Pharmaceutical ManufacturingNew Jersey, United States201-500 Employees
Halo Pharma, Inc. functions as a pharmaceutical CDMO, providing services that span dosage form development, commercial manufacturing, and analytical testing to support drug development and production. Its client base comprises pharmaceutical companies that require end-to-end CDMO capability, from clinical and commercial APIs through to finished drug products. As a member of the Normaco Group, Halo integrates with Noramco and Purisys to offer a North American supply chain solution for both clinical and commercial products. Headquartered in Whippany, New Jersey, Halo also operates facilities in Montreal and Mirabel, Quebec, and employs several hundred people. A 2026 development has Halo launching sterile injectable manufacturing, expanding its capability set to include sterile filling and related processes.